Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Secondary Progressive Multiple Sclerosis Drug Market Data Survey Report 2025

  • HEY2872602
  • 86 Pages
  • January 2018
  • Medical Devices
Download Sample    Get Discount   
 
Summary

The global Secondary Progressive Multiple Sclerosis Drug market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Major Application

Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

AB Science SA 

Actelion Ltd 

Biogen, Inc. 

F. Hoffmann-La Roche Ltd. 

Genzyme Corporation 

Glialogix, Inc. 

Glialogix, Inc. 

Innate Immunotherapeutics Ltd 

Kyorin Pharmaceutical Co., Ltd. 

Mallinckrodt Plc 

MedDay SA 

MedImmune, LLC 

Merck KGaA 

Meta-IQ ApS 

Novartis AG 

Opexa Therapeutics, Inc. 

Xenetic Biosciences (UK) Limited

Major applications as follows:

Hospital 

Clinic 

Others

Major Type as follows:

Inebilizumab 

GLX-1112 

DC-TAB 

Etomoxir 

IB-MS 

Others

Regional market size, production data and export & import:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Global Market Overview

1.1 Scope of Statistics

1.1.1 Scope of Products

1.1.2 Scope of Manufacturers

1.1.3 Scope of Application

1.1.5 Scope of Regions/Countries

1.2 Global Market Size

2 Regional Market

2.1 Regional Production

2.2 Regional Demand

2.3 Regional Trade

3 Key Manufacturers

3.1 AB Science SA 

3.1.2 Company Information

3.1.2 Product Specifications

3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.2 Actelion Ltd 

3.2.1 Company Information

3.2.2 Product Specifications

3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.3 Biogen, Inc. 

3.3.1 Company Information

3.3.2 Product Specifications

3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.4 F. Hoffmann-La Roche Ltd. 

3.4.1 Company Information

3.4.2 Product Specifications

3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.5 Genzyme Corporation 

3.5.1 Company Information

3.5.2 Product Specifications

3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.6 Glialogix, Inc. 

3.6.1 Company Information

3.6.2 Product Specifications

3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.7 Glialogix, Inc. 

3.7.1 Company Information

3.7.2 Product Specifications

3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.8 Innate Immunotherapeutics Ltd 

3.8.1 Company Information

3.8.2 Product Specifications

3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.9 Kyorin Pharmaceutical Co., Ltd. 

3.9.1 Company Information

3.9.2 Product Specifications

3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.10 Mallinckrodt Plc 

3.10.1 Company Information

3.10.2 Product Specifications

3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.11 MedDay SA 

3.12 MedImmune, LLC 

3.13 Merck KGaA 

3.14 Meta-IQ ApS 

3.15 Novartis AG 

3.16 Opexa Therapeutics, Inc. 

3.17 Xenetic Biosciences (UK) Limited

4 Major Application

4.1 Hospital 

4.1.1 Overview

4.1.2 Hospital  Market Size and Forecast

4.2 Clinic 

4.2.1 Overview

4.2.2 Clinic  Market Size and Forecast

4.3 Others

4.3.1 Overview

4.3.2 Others Market Size and Forecast

5 Market by Type

5.1 Inebilizumab 

5.1.1 Overview

5.1.2 Inebilizumab  Market Size and Forecast

5.2 GLX-1112 

5.2.1 Overview

5.2.2 GLX-1112  Market Size and Forecast

5.3 DC-TAB 

5.3.1 Overview

5.3.2 DC-TAB  Market Size and Forecast

5.4 Etomoxir 

5.4.1 Overview

5.4.2 Etomoxir  Market Size and Forecast

5.5 IB-MS 

5.5.1 Overview

5.5.2 IB-MS  Market Size and Forecast

5.6 IB-MS 

5.6.1 Overview

5.6.2 IB-MS  Market Size and Forecast

6 Conclusion

Tab Regional Production 2011-2017 (Million USD)

Tab Regional Production 2011-2017 (Volume)

Tab Regional Demand and CAGR 2011-2017 (Million USD)

Tab Regional Demand and CAGR 2011-2017 (Volume)

Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)

Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)

Tab Regional Export 2011-2017 (Million USD)

Tab Regional Export 2011-2017 (Volume)

Tab Regional Import 2011-2017 (Million USD)

Tab Regional Import 2011-2017 (Volume)

Tab Sales Revenue, Volume, Price, Cost and Margin of AB Science SA 

Tab Sales Revenue, Volume, Price, Cost and Margin of Actelion Ltd 

Tab Sales Revenue, Volume, Price, Cost and Margin of Biogen, Inc. 

Tab Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd. 

Tab Sales Revenue, Volume, Price, Cost and Margin of Genzyme Corporation 

Tab Sales Revenue, Volume, Price, Cost and Margin of Glialogix, Inc. 

Tab Sales Revenue, Volume, Price, Cost and Margin of Glialogix, Inc. 

Tab Sales Revenue, Volume, Price, Cost and Margin of Innate Immunotherapeutics Ltd 

Tab Sales Revenue, Volume, Price, Cost and Margin of Kyorin Pharmaceutical Co., Ltd. 

Tab Sales Revenue, Volume, Price, Cost and Margin of Mallinckrodt Plc 

Tab Sales Revenue, Volume, Price, Cost and Margin of MedDay SA 

Tab Sales Revenue, Volume, Price, Cost and Margin of MedImmune, LLC 

Tab Sales Revenue, Volume, Price, Cost and Margin of Merck KGaA 

Tab Sales Revenue, Volume, Price, Cost and Margin of Meta-IQ ApS 

Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis AG 

Tab Sales Revenue, Volume, Price, Cost and Margin of Opexa Therapeutics, Inc. 

Tab Sales Revenue, Volume, Price, Cost and Margin of Xenetic Biosciences (UK) Limited

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450